Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in Production

Core Insights - Kraig Biocraft Laboratories, Inc. has commenced production of its BAM1 recombinant spider silk hybrids, accelerating its 2024 production schedule due to successful production trials [1][3] - The current production cycle represents a significant increase, with over a 10X rise in production compared to spring trials, marking the largest single batch in the company's history [1][2] - The BAM-1 hybrids have shown excellent hatching yield and robust growth, with no signs of disease or weakness observed in the colony [2] Company Developments - The BAM-1 hybrids were developed by integrating the company's Dragon Silk™ technology into two commercial silkworm strains, resulting in larger cocoons and improved silk yield [2] - The successful launch is attributed to over a year of focused development, positioning the company to achieve its first production milestone of a metric ton of spider silk [3] - The company plans to provide further updates on production growth and market developments in the coming weeks [3] Industry Context - Kraig Labs is recognized as a leading developer of genetically engineered spider silk-based fiber technologies, with significant implications for the global textile industry [4]